Clinical trials show mean weight reductions of 1522% over 68 weeks, but individual outcomes range from minimal loss to dramatic reductions, reflecting underlying metabolic heterogeneity
Common side effects of Rybelsus are nausea, stomach pain, diarrhea, decreased appetite, vomiting, and/or constipation
Second, despite accounting for many relevant covariates in the adjustment and employing IPTW techniques, we may have missed some potentially relevant information and thus we cannot rule out residual confounding
These medications intended for diabetes and weight loss can help addiction without the associated stigma, which will be a new window for how to deal with addiction. The protective effects were consistent and even applied to people with Type 2 diabetes, obesity, or both conditions
And that's precisely where the arginate salt story begins